Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Oct;7(10):e00936.
doi: 10.1002/mgg3.936. Epub 2019 Aug 15.

Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta-analysis

Shulong Zhang  1 , Kaihua Zhu  1 , Zuoliang Zhang  1 , Hui Wang  1 , Xiaolong Wang  1
Affiliations
Meta-Analysis

Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta-analysis

Shulong Zhang et al. Mol Genet Genomic Med. 2019 Oct.

Abstract

Background: The association between a 4-bp indel polymorphism (rs10680577) within the distal promoter of EGLN2 and cancer risk has been investigated by several case-control studies in recent years, but investigation results were inconsistent. Thus, a systematic assessment of the association was performed based on a literature review and pooled analysis.

Methods: Two investigators independently retrieved relevant studies from PubMed, Chinese National Knowledge Infrastructure (CNKI), Embase, and Google Scholar. The fixed or random effects model was selected to calculate odds ratios (ORs) with 95% confidence intervals (CIs) based on heterogeneity level. All analyses including heterogeneity assessment, subgroup analysis, sensitivity analysis, and publication bias assessment were performed using RevMan 5.3 software and Stata 12.0 software.

Results: A total of six relevant studies with 3,406 cases and 5,147 controls were included in the final analysis. The overall pooled analysis showed that EGLN2 rs10680577 polymorphism was significantly associated with cancer risk under all genetic models. However, subgroup analysis based on cancer type showed that the polymorphism was significantly associated with the risk of digestive system cancer under all genetic models, and with the risk of lung cancer under dominant model, heterozygote comparison model, and allele comparison model. Subgroup analysis based on population sources showed a significant association in Chinese population under all genetic models.

Conclusion: The present result suggests that EGLN2 rs10680577 polymorphism is associated with cancer risk, and may act as a promising predictive biomarker for cancer risk, especially in Chinese population. However, further well-designed studies are warranted to confirm these results.

Keywords: EGLN2; cancer; polymorphism; risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of literature selection
Figure 2
Figure 2
Forest plots for the associations between EGLN2 rs10680577 polymorphism and cancer risk in the overall population (a: dominant model; b: recessive model; c: homozygote comparison model; d: heterozygote comparison model; e: allele comparison model)
Figure 3
Figure 3
Funnel plots for the association of EGLN2 rs10680577 polymorphism and cancer risk in the overall population (a: dominant model; b: recessive model; c: homozygote comparison model; d: heterozygote comparison model; e: allele comparison model)
See this image and copyright information in PMC

References

    1. Che, J. , Jiang, D. , Zheng, Y. , Zhu, B. , Zhang, P. , Lu, D. , … Wang, M. (2014). Polymorphism in PHD1 gene and risk of non‐small cell lung cancer in a Chinese population. Tumour Biology, 35(9), 8921–8925. 10.1007/s13277-014-2112-9 - DOI - PubMed
    1. Chen, B. , Wang, S. , Ma, G. , Han, J. , Zhang, J. , Gu, X. , & Feng, X. (2018). The association of POLR2E rs3787016 polymorphism and cancer risk: A Chinese case‐control study and meta‐analysis. Bioscience Reports, 38(6), BSR20180853 10.1042/bsr20180853 - DOI - PMC - PubMed
    1. Erez, N. , Milyavsky, M. , Eilam, R. , Shats, I. , Goldfinger, N. , & Rotter, V. (2003). Expression of prolyl‐hydroxylase‐1 (PHD1/EGLN2) suppresses hypoxia inducible factor‐1alpha activation and inhibits tumor growth. Cancer Research, 63(24), 8777–8783. - PubMed
    1. Gao, X. , Yang, J. , Wang, M. , & Zhang, J. (2016). TCF21 genetic polymorphisms and breast cancer risk in Chinese women. Oncotarget, 7(34), 55757–55764. 10.18632/oncotarget.9825 - DOI - PMC - PubMed
    1. Gu, X. I. , Feng, J. , Liu, L. , Lu, M. , Ma, X. , Cao, Y. , … Zhao, Q. (2018). Association of MUC1 rs4072037 functional polymorphism and cancer risk: Evidence from 12551 cases and 13436 controls. Journal of Cancer, 9(18), 3343–3351. 10.7150/jca.25515 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources